ArticleNeuro-oncology2025

Multimodal glioma immunotherapy combining TLR9-targeted STAT3 antisense oligodeoxynucleotides with PD1 immune checkpoint blockade.

Chia-Yang Hung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.